InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

8.25
Delayed Data
As of 1:29pm ET
 -0.28 / -3.28%
Today’s Change
7.71
Today|||52-Week Range
107.50
-57.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$24.7M

Company Description

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which focuses on the treatment of spinal cord injuries. Its treatment approach is the Neuro-Spinal Scaffold implant, which is designed for implantation at the site of injury within a spinal cord and is intended to treat acute SCI. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in 2005 and is headquartered in Cambridge, MA.

Contact Information

Invivo Therapeutics Holdings Corp.
One Kendall Square
Cambridge Massachusetts 02139
P:(617) 863-5500
Investor Relations:

Employees

Shareholders

Other institutional6.13%
Mutual fund holders4.25%
Individual stakeholders0.65%

Top Executives

Richard ToselliPresident, Chief Executive Officer & Director
William D'AgostinoSenior Vice President-Operations
Christopher McNultyChief Financial & Accounting Officer
Tamara Lynn JosephChief Compliance Officer, SVP & General Counsel
Jay BlackingtonVice President & Head-Human Resources